Valuation: Waldencast plc

Market Cap 101M 91.24M 85.15M 77.17M 145M 9.66B 146M 1.02B 399M 5.01B 381M 373M 16.12B P/E 2026 *
-1.7x
P/E 2027 * -1.93x
Enterprise Value 101M 91.24M 85.15M 77.17M 145M 9.66B 146M 1.02B 399M 5.01B 381M 373M 16.12B EV / Sales 2026 *
0.35x
EV / Sales 2027 * 0.32x
Free-Float
44.64%
Yield 2026 *
-
Yield 2027 * -
09-24 Waldencast Files to Delist Shares, Warrants From Nasdaq MT
09-20 Waldencast plc(NasdaqCM:WALD) added to S&P Global BMI Index CI
09-14 Top Premarket Decliners MT
09-14 Waldencast Plans Voluntary Nasdaq Delisting; Shares Down Pre-Bell MT
07-29 Bridgepoint Europe VII and Bridgepoint Europe VII 2 LP, funds managed by Bridgepoint Advisers Limited, and Gore Range Capital Fund III Llc, a fund managed by Gore Range Capital LLC, acquired Obagi Cosmeceuticals LLC, Obagi Netherlands B.V. and Obagi AsiaPac Limited from Waldencast plc. CI
06-15 Waldencast plc Announces Fda Approval of Obagi Saypha Chiq Injectable Hyaluronic Acid Gel CI
06-15 Waldencast Says US FDA Approves Obagi Saypha ChIQ Injectable Hyaluronic Acid Gel MT
06-01 Waldencast plc Announces CEO Changes CI
06-01 Waldencast plc Announces Board Changes, Effective June 1, 2026 CI
06-01 Waldencast announces sale of Obagi Medical to Bridgepoint RE
05-31 Bridgepoint Europe VII and Bridgepoint Europe VII 2 LP, funds managed by Bridgepoint Advisers Limited, and Gore Range Capital Fund III Llc, a fund managed by Gore Range Capital LLC, entered into a definitive agreement to acquire Obagi Cosmeceuticals LLC, Obagi Netherlands B.V. and Obagi AsiaPac Limited from Waldencast plc for $460 million. CI
05-15 Obagi Medical Shares New Data on Recent Innovations At Music City Symposium for Cosmetic Advances and Laser Education Meeting CI
05-14 Obagi Medical And Next Health Form Strategic Alliance To Launch The Skin Recharge Station Pop-Up Experience CI
1 week-7.62%
Current month+12.86%
1 month-25.95%
3 months-41.92%
6 months-7.62%
Current year-48.40%
1 week 0.65
Extreme 0.65
1
1 month 0.65
Extreme 0.65
1.18
Current year 0.65
Extreme 0.65
2.01
1 year 0.65
Extreme 0.65
3.22
3 years 0.65
Extreme 0.65
12
5 years 0.65
Extreme 0.65
12.1
10 years 0.65
Extreme 0.65
12.1
Manager TitleAgeSince
Chief Executive Officer 60 2026-07-29
General Counsel - 2023-08-31
Director TitleAgeSince
Chairman 60 2020-12-31
Director/Board Member 60 2021-11-30
Director/Board Member 52 2021-02-28
Date Insider Type Main position Quantity % Market Cap. Importance
8/28/26
Zeno Equity Partners LLP
BuyCompany 335,000 0.2774%
7/30/26 Exercice

Chief Financial Officer

158,578 0.1313%
7/30/26 Issuer sale

Founder

-193,816 0.1605%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-7.62% - - 101M
Average 0.00%
Weighted average by Cap. 0.00%

Financials

2026 *2027 *
Net sales 287M 258M 240M 218M 409M 27.27B 412M 2.89B 1.13B 14.15B 1.08B 1.05B 45.52B 318M 286M 266M 241M 453M 30.22B 456M 3.2B 1.25B 15.69B 1.19B 1.17B 50.45B
Net income -57.81M -51.97M -48.5M -43.96M -82.53M -5.5B -83.04M -582M -227M -2.86B -217M -212M -9.18B -51.81M -46.59M -43.47M -39.4M -73.98M -4.93B -74.44M -522M -204M -2.56B -195M -190M -8.23B
Net Debt - -
Projected Income Statement - Annual - Waldencast plc
Logo Waldencast plc
Waldencast plc is a global multi-brand beauty and wellness platform. It is focused on developing, acquiring, accelerating, and scaling conscious and purpose-driven brands. Its segments include Obagi Medical and Milk Makeup. The Obagi Medical segment sells advanced skincare products backed by science and formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines and wrinkles, and to protect and enhance skin tone and texture. Its portfolio of medical-grade skincare with consumer-centric, in-office injectable procedures includes Saypha ChIQ, and MagIQ lines of injectable hyaluronic acid gels. The Milk Makeup segment consists of the business of Milk. Its Milk’s business activities include developing, marketing, and selling cosmetics, skincare, and other beauty products. Its Milk Makeup segment offers over 250 products through its United States Website www.MilkMakeup.com and retail partners include Sephora globally and Ulta Beauty in the United States.
Employees
367
Date Price Change Volume
26-10-13 US$0.8501 +11.84% 28,686
26-10-12 US$0.7601 +1.35% 131,174
26-10-09 US$0.7500 -21.05% 32,849
26-10-08 US$0.9500 -2.06% 4,677
26-10-07 US$0.9700 -7.62% 27,028
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Waldencast plc
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
0.8501USD
Average target price
2.050USD
Spread / Average Target
+141.15%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Waldencast plc
  1. Stock Market
  2. Stocks
  3. MLKMF Stock